EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

FOXA2 activates HIF2α expression to promote tumor progression and is regulated by the E3 ubiquitin ligase VHL in renal cell carcinoma

Dongjun Yang, Qixiang Li, Peifen Lu, Dongliang Wu, Wenyang Li, Xingjun Meng, Mengying Xing, Wenbing Shangguan, Bing Chen, Jie Yang, Zhihong Zhang, Zengjun Wang und 2 weitere

Journal of Biological Chemistry · 2024

DOI: 10.1016/j.jbc.2023.105535 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024. Verfasst von Dongjun Yang und 13 weiteren Autor:innen. Beteiligte Einrichtung: The State Key Laboratory of Pharmaceutical Biotechnology, Department of Hematology, The Affiliated Drum Tower Hospital of Nanjing University Medical …. Hauptthemen laut MEDLINE: Basic Helix-Loop-Helix Proteins, Carcinoma, Renal Cell, Hepatocyte Nuclear Factor 3-beta, Kidney Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Jiangsu Provincial Department of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Renal cell carcinoma (RCC) is a frequent malignancy of the urinary system with high mortality and morbidity. However, the molecular mechanisms underlying RCC progression are still largely unknown. In this study, we identified FOXA2, a pioneer transcription factor, as a driver oncogene for RCC. We show that FOXA2 was commonly upregulated in human RCC samples and promoted RCC proliferation, as evidenced by assays of cell viability, colony formation, migratory and invasive capabilities, and stemness properties. Mechanistically, we found that FOXA2 promoted RCC cell proliferation by transcriptionally activating HIF2α expression in vitro and in vivo. Furthermore, we found that FOXA2 could interact with VHL (von Hippel‒Lindau), which ubiquitinated FOXA2 and controlled its protein stability in RCC cells. We showed that mutation of lysine at position 264 to arginine in FOXA2 could mostly abrogate its ubiquitination, augment its activation effect on HIF2α expression, and promote RCC proliferation in vitro and RCC progression in vivo. Importantly, elevated expression of FOXA2 in patients with RCC positively correlated with the expression of HIF2α and was associated with shorter overall and disease-free survival. Together, these findings reveal a novel role of FOXA2 in RCC development and provide insights into the underlying molecular mechanisms of FOXA2-driven pathological processes in RCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Basic Helix-Loop-Helix ProteinsCarcinoma, Renal CellHepatocyte Nuclear Factor 3-betaKidney NeoplasmsHumansCell Line, TumorTranscription FactorsVon Hippel-Lindau Tumor Suppressor ProteinDisease ProgressionEndothelial PAS Domain-Containing Protein 1

Stichwörter der Autor:innen

FOXA2HIF2αVHLcell proliferationgene expressionrenal cell carcinoma

Substanzen

Basic Helix-Loop-Helix ProteinsHepatocyte Nuclear Factor 3-betaTranscription FactorsVon Hippel-Lindau Tumor Suppressor ProteinEndothelial PAS Domain-Containing Protein 1FOXA2 protein, humanVHL protein, human

Autor:innen und Institutionen

  • The State Key Laboratory of Pharmaceutical Biotechnology, Department of Hematology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, China-Australia Institute of Translational Medicine, School of…
  • Department of Urology and Pathology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Department of Medical Biology, The Walter and Eliza Hall Institute of Medical Research, University of Melbourne, Melbourne, Victoria, Australia.

Förderung

  • National Natural Science Foundation of China
  • Jiangsu Provincial Department of Science and Technology

Zitieren

APA

Yang, D., Li, Q., Lu, P., Wu, D., Li, W., Meng, X., Xing, M., Shangguan, W., Chen, B., Yang, J., Zhang, Z., Wang, Z., Huang, D. C. S., & Zhao, Q. (2024). FOXA2 activates HIF2α expression to promote tumor progression and is regulated by the E3 ubiquitin ligase VHL in renal cell carcinoma. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2023.105535

Vancouver

Yang D, Li Q, Lu P, Wu D, Li W, Meng X, et al. FOXA2 activates HIF2α expression to promote tumor progression and is regulated by the E3 ubiquitin ligase VHL in renal cell carcinoma. Journal of Biological Chemistry. 2024. doi:10.1016/j.jbc.2023.105535

BibTeX
@article{Yang2024,
  author = {Yang, Dongjun and Li, Qixiang and Lu, Peifen and Wu, Dongliang and Li, Wenyang and Meng, Xingjun and Xing, Mengying and Shangguan, Wenbing and Chen, Bing and Yang, Jie and Zhang, Zhihong and Wang, Zengjun and Huang, David C S and Zhao, Quan},
  title = {FOXA2 activates HIF2α expression to promote tumor progression and is regulated by the E3 ubiquitin ligase VHL in renal cell carcinoma},
  journal = {Journal of Biological Chemistry},
  year = {2024},
  doi = {10.1016/j.jbc.2023.105535}
}
Kostenlos starten →